SCHEMBL13344367

SCHEMBL13344367

Cc1ccc(S(=O)(=O)SCCCCCCSS(=O)(=O)c2ccc(C)cc2)cc1

nearest known ligand 0.89

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
G6PD P11413 2/20 0.89
BCHE P06276 10/20 0.56
ACHE P22303 10/20 0.56
DNMT1 P26358 1/20 0.52
ALDH1A1 P00352 3/20 0.48
CYP3A4 P08684 1/20 0.48
CYP2C9 P11712 1/20 0.48
CYP2C19 P33261 1/20 0.48
GAA P10253 2/20 0.46
CA12 O43570 1/20 0.43
CA1 P00915 1/20 0.43
CA2 P00918 1/20 0.43
CA3 P07451 1/20 0.43
CA6 P23280 1/20 0.43
CA5A P35218 1/20 0.43
CA7 P43166 1/20 0.43
CA9 Q16790 1/20 0.43
CA5B Q9Y2D0 1/20 0.43
TLR9 Q9NR96 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11025388 1.00 G6PD (0.89) G6PDBCHEACHEDNMT1ALDH1A1
SCHEMBL20595267 0.98 G6PD (0.92) G6PDBCHEACHEDNMT1ALDH1A1
SCHEMBL14024173 0.94 G6PD (1.00) G6PDBCHEACHEDNMT1ALDH1A1
SCHEMBL27395584 0.93 G6PD (0.77) G6PDBCHEACHEDNMT1ALDH1A1
SCHEMBL27395596 0.93 G6PD (0.77) G6PDBCHEACHEDNMT1ALDH1A1
SCHEMBL11295158 0.93 G6PD (0.77) G6PDBCHEACHEDNMT1ALDH1A1
SCHEMBL19616577 0.91 G6PD (0.74) G6PDBCHEACHEDNMT1ALDH1A1
SCHEMBL19616439 0.91 G6PD (0.74) G6PDBCHEACHEDNMT1ALDH1A1
SCHEMBL29158190 0.91 G6PD (0.74) G6PDBCHEACHEDNMT1ALDH1A1
SCHEMBL10330805 0.91 G6PD (0.79) G6PDBCHEACHEDNMT1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8334340-B2 Sulfur-containing cycloaliphatic compound, process for its preparation, filled sulfur-vulcanizable elastomer composition containing same and articles fabricated therefrom MOMENTIVE PERFORMANCE MATERIALS, INC. (US) 2012-12-18 US disclosed
US-8334340-B2 Sulfur-containing cycloaliphatic compound, process for its preparation, filled sulfur-vulcanizable elastomer composition containing same and articles fabricated therefrom MOMENTIVE PERFORMANCE MATERIALS, INC. (US) 2012-12-18 US disclosed
US-20100113681-A1 Sulfur-containing cycloaliphatic compound, process for its preparation, filled sulfur-vulcanizable elastomer composition containing same and articles fabricated therefrom MOMENTIVE PERFORMANCE MATERIALS INC. 2010-05-06 US disclosed
US-20100113681-A1 Sulfur-containing cycloaliphatic compound, process for its preparation, filled sulfur-vulcanizable elastomer composition containing same and articles fabricated therefrom MOMENTIVE PERFORMANCE MATERIALS INC. 2010-05-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100113681-A1 Sulfur-containing cycloaliphatic compound, process for its preparation, filled sulfur-vulcanizable elastomer composition containing same and articles fabricated therefrom CRHR2, COPE, NR3C2 G6PD 4108/4885BCHE 3532/4885ACHE 4665/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.